High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$5.1M
$5,108,835
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
COLL
S
COLLEGIUM PHARMACEUTICAL, INC
Dieter David
• Officer • EVP & General Counsel
10b5-1 Sell
2026-03-09
$228,110
|
||||||
| COLL |
COLLEGIUM PHARMACEUTICAL, INC
|
Officer • EVP & General Counsel
10b5-1 Sell
|
2026-03-09 | $228,110 | S | Form 4 |
|
COLL
S
COLLEGIUM PHARMACEUTICAL, INC
Dreyer Scott
• Officer • EVP & Chief Commercial Officer
10b5-1 Sell
2026-03-03
$2,019,437Largex2
|
||||||
| COLL |
COLLEGIUM PHARMACEUTICAL, INC
|
Officer • EVP & Chief Commercial Officer
10b5-1 Sell
|
2026-03-03 | $2,019,437Largex2 | S | Form 4 |
|
COLL
S
COLLEGIUM PHARMACEUTICAL, INC
Fallon John A.
• Director
Discretionary SellΔOwn -35.0%
2025-11-12
$1,645,536Large
|
||||||
| COLL |
COLLEGIUM PHARMACEUTICAL, INC
|
Director
Discretionary SellΔOwn -35.0%
|
2025-11-12 | $1,645,536Large | S | Form 4 |
| COLL |
COLLEGIUM PHARMACEUTICAL, INC
|
CFO
10b5-1 Sell
|
2025-11-06 | $1,215,753Largex2 | S | Form 4 |